Knee osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ( 1 ) In line with the clinical diagnostic criteria of knee osteoarthritis ( using the diagnostic criteria proposed by the Chinese Medical Association in 2023 ) : 1 Repeated knee pain in the past 1 month ; 2 age = 50 years old ; 3 morning stiffness time = 30 min ; 4 bone friction sound ( sense ) during activity ; 5 X-ray film ( standing or weight-bearing position ) showed joint space narrowing, subchondral bone sclerosis and / or cystic degeneration, and osteophyte formation at the joint margin ; mRI showed cartilage injury, osteophyte formation, subchondral bone marrow edema and ( or ) cystic degeneration, meniscus degenerative tear, partial or full-thickness cartilage loss. Meet the diagnostic criteria 1 + 2 + 3 + 4 or 1 + 5 or 1 + 6, can be diagnosed. (2) Have repeated pain in the past month, with mild to moderate pain intensity (NRS of 1-6 points); (3) Age ranges from 40 to 75 years old, with unilateral knee involvement, regardless of gender; (4) Have good tolerance to scalpel-needle therapy, able to actively cooperate, and have good compliance; (5) Voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with knee joint lesions caused by metabolic, infectious, and congenital reasons, such as gouty arthritis and rheumatic arthritis; (2) Patients with severe underlying diseases, such as cardiopulmonary insufficiency, tumors, hematologic diseases, diabetes, or peripheral neuropathy; (3) Patients with knee joint trauma, fractures, surgical history, or local skin ulcers, masses, damage, or infection; (4) Patients with a severe bleeding tendency, including those currently using anticoagulants; (5) Patients with a history of needle fear or needle syncope, or those unable to tolerate needle knife therapy due to old age, physical weakness, mental stress, hunger, fatigue, or other reasons; (6) Patients who have received other forms of treatment for this condition within 2 weeks, such as hormone closure or oral analgesic drugs, or those who participated in other clinical trials that may affect the results of this study; (7) Patients with poor compliance, inability to cooperate, inability to comply with the requirements of the trial, or unwillingness to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Western Ontario and McMaster Universities Osteoarthritis Index Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Numerical pain assessment scale;Quality of Life Rating Scale ( SF-12 ); | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Traditional Chinese Medicine , Guangdong, China